US Drug Recall Register
Class II · Moderate risk Completed Initiated Nov 14, 2023 (3 years ago)

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed pH Specifications

What was recalled

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

Recalling firm
Baxter Healthcare Corporation
NDC code
36000-012-25
Origin
IL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0146-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ondansetron recalls

See all